Published in J Gen Virol on November 01, 1999
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J Virol (2005) 1.72
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. J Virol (2004) 1.29
HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol (2006) 1.13
Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest (2002) 1.11
Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J Gastroenterol (2001) 0.94
Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid (2013) 0.92
Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro. World J Gastroenterol (2006) 0.88
Diversity of hepatitis C virus quasispecies evaluated by denaturing gradient gel electrophoresis. Clin Diagn Lab Immunol (2001) 0.85
Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway. PLoS One (2012) 0.84
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis. World J Gastroenterol (2006) 0.82
New Methods in Tissue Engineering: Improved Models for Viral Infection. Annu Rev Virol (2014) 0.81
Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein. World J Gastroenterol (2002) 0.80
Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus. World J Gastroenterol (2005) 0.80
Human liver transplantation as a model to study hepatitis C virus pathogenesis. Liver Transpl (2009) 0.79
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2. Virol J (2011) 0.79
Advancement in the development of models for hepatitis C research. J Biomed Biotechnol (2012) 0.78
The missing pieces of the HCV entry puzzle. Future Virol (2015) 0.76
Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture. Int J Biomed Sci (2008) 0.75
High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24
Almost the entire 5' non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett (1995) 2.72
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology (1998) 2.62
Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet (1997) 2.54
Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J (1985) 2.49
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology (2001) 2.49
Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol (1999) 2.41
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Immunity in hepatitis C infection. J Infect Dis (1992) 2.28
Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet (1992) 2.25
Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol (1988) 2.11
Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol (1999) 2.09
In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood (1998) 1.98
Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology (1993) 1.95
High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol (2001) 1.94
Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene (2006) 1.94
NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med (1988) 1.88
Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology (2000) 1.87
Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J (1994) 1.87
Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology (1990) 1.84
Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med (1996) 1.81
Microtubule-dependent control of cell shape and pseudopodial activity is inhibited by the antibody to kinesin motor domain. J Cell Biol (1993) 1.79
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest (1996) 1.79
Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology (1995) 1.77
Nonsurgical treatment of duodenal perforation by endoscopic repair using a clipping device. Gastrointest Endosc (1999) 1.72
Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol (1999) 1.72
A genomic approach of the hepatitis C virus generates a protein interaction map. Gene (2000) 1.72
Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol (1993) 1.71
Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Exp Cell Res (1983) 1.68
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66
Long-term co-cultures of adult human hepatocytes with rat liver epithelial cells: modulation of albumin secretion and accumulation of extracellular material. Hepatology (1984) 1.62
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Br J Cancer (2007) 1.61
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol (2000) 1.59
In vivo measurement of the elastic modulus of the human periodontal ligament. Med Eng Phys (2001) 1.59
Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell (1988) 1.58
Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol (1998) 1.57
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B. Hepatology (2000) 1.56
Transmission of and liver injury by TT virus in patients on maintenance hemodialysis. J Gastroenterol (1999) 1.55
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol (1984) 1.55
The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol Cell Biol (1999) 1.54
Impaired cough reflex in patients with recurrent pneumonia. Thorax (2003) 1.53
cDNA cloning and expression analysis of new members of the mammalian F-box protein family. Genomics (2000) 1.52
Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost (1996) 1.51
Modulation of functional activities in cultured rat hepatocytes. Mol Cell Biochem (1983) 1.51
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology (1998) 1.50
Successful living-related partial liver transplantation to an adult patient. Lancet (1994) 1.47
Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal. Virology (1992) 1.47
Clinical impact of occult HBV infections. J Clin Virol (2005) 1.46
Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol (1997) 1.45
A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer (1991) 1.45
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44
Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol (1995) 1.44
Dependence of hepatocyte-specific gene expression on cell-cell interactions in primary culture. EMBO J (1985) 1.44
Automated body contour detection in SPECT: effects on quantitative studies. J Nucl Med (1986) 1.41
[Pancreaticoduodenectomy for cancer of the head of the pancreas]. J Chir (Paris) (2008) 1.41
Predictions of liver histology from laboratory tests and demographic data [corrected]. Lancet (1998) 1.39
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient with myeloproliferative disorder. Intern Med (1996) 1.38
A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol (2001) 1.38
Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer (1993) 1.37
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology (1998) 1.37
In vitro replication competence of a cloned hepatitis B virus variant with a nonsense mutation in the distal pre-C region. Virology (1991) 1.36
Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) (1995) 1.35
Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem (1996) 1.33
Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature (1984) 1.33
Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr (2001) 1.31
Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy (2009) 1.30
Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones. J Gastroenterol Hepatol (1999) 1.30
Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis (1998) 1.29
Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature (1987) 1.25
Duck hepatitis B virus can tolerate insertion, deletion, and partial frameshift mutation in the distal pre-S region. J Virol (1989) 1.23
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst (2000) 1.23
Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol (2009) 1.22
Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature. Am J Gastroenterol (1998) 1.21
Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods (1996) 1.20
The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology (1996) 1.19